Global Viral Vector CDMO Services Supply, Demand and Key Producers, 2023-2029

Global Viral Vector CDMO Services Supply, Demand and Key Producers, 2023-2029

The global Viral Vector CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.

CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.

CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.

This report studies the global Viral Vector CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Viral Vector CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Viral Vector CDMO Services total market, 2018-2029, (USD Million)

Global Viral Vector CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Viral Vector CDMO Services total market, key domestic companies and share, (USD Million)

Global Viral Vector CDMO Services revenue by player and market share 2018-2023, (USD Million)

Global Viral Vector CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)

Global Viral Vector CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Viral Vector CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed） and Gene Universal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector CDMO Services market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Viral Vector CDMO Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Viral Vector CDMO Services Market, Segmentation by Type
AAV
Lentivirus
Adenovirus
HSV
Others

Global Viral Vector CDMO Services Market, Segmentation by Application
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others

Companies Profiled:
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology
Hillgene
Asymchem
Exthera
Flash Therapeutics
VIVEBiotech
FinVector
uBriGene
Eurogentec
VGXI

Key Questions Answered

1. How big is the global Viral Vector CDMO Services market?

2. What is the demand of the global Viral Vector CDMO Services market?

3. What is the year over year growth of the global Viral Vector CDMO Services market?

4. What is the total value of the global Viral Vector CDMO Services market?

5. Who are the major players in the global Viral Vector CDMO Services market?